Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Human Pathology|June 17, 2020
A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutationsTimothy I Miller, Nicholas A Zoumberos, Bryan Johnson, et al.
The Journal of Investigative Dermatology|December 11, 2012
Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysisPaul W Harms, Rajiv M Patel, Monique E Verhaegen, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2019
Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomasMay P Chan, Komal R Plouffe, Chia-Jen Liu, et al.
Oncogene|August 25, 2004
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profilesSubbaya Subramanian, Robert B West, Christopher L Corless, et al.
JAMA Surgery|February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III MelanomaIrene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive BiomarkersKelly L Harms, Lili Zhao, Bryan Johnson, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
Pageof 14